Le mode conseil est activé Arrêter

BTEE - iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) (IE00BDZVHG35)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

Sélectionnez tout Réinitialiser tout
 
(%)
IE00BDZVHG35
BTEE ISIN
Fonds négociés en bourse (FNB)
Type de fonds
BlackRock
Fournisseur
9,83 USD
valeur liquidative par action | 08/07/2026
05/03/2018
Date de lancement
2 fois par an
Paiement de dividendes
CEOIES
CFI
BTEE
Ticker
Formed
Status
Equity
Objet d'investissement
Biotech
Secteur
USA
Géographie
Nasdaq Biotechnology Index(R)
Benchmark
0.35 %
Ratio de coût total
1.199,39 mln USD
Actif total du fonds | 09/07/2026
74,87 mln USD
Volume des actits de classe "actions" | 08/07/2026
Oui
UCITS

Dernières données pour
Ajouter à comparer
de
au
ADD-IN
Add-in Cbonds API
bond data api

Cotations (BTEE)

Explorer la base de données la plus complète

1 000 000

obligations

80 234

actions

175 910

ETF & Funds

80 000

indices

Suivre votre portefeuille de la manière la plus efficace

  • Screener d'obligations
  • liste de surveillance
  • Excel ADD-IN
Obtenir l'accès

Dynamique des prix

Fund profile

The iShares Nasdaq US Biotechnology UCITS ETF seeks to replicate as close as possible the price and yield performance of the NASDAQ Biotechnology Index by investing in a portfolio comprised primarily of biotechnology and pharmaceutical equities listed on the NASDAQ

BTEE profile

The iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The BlackRock fund’s base currency is USD and the share class was registered 05.03.2018 with unique ISIN - IE00BDZVHG35. Main exchange is London S.E. (USD) and ticker symbol is BTEE. The total expense ratio is 0.35%. The iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) pays dividends 2 time(s) per year.

Structure BTEE au 07/07/2026

Exporter la structure dans Excel
Titre Valeur
VERTEX PHARMACEUTICALS INC 8,18%
AMGEN INC 7,66%
GILEAD SCIENCES INC 7,11%
REGENERON PHARMACEUTICALS INC 4,66%
ALNYLAM PHARMACEUTICALS INC 2,87%
REVOLUTION MEDICINES INC 2,71%
MODERNA INC 2,12%
BIOGEN INC 2,03%
ILLUMINA INC 1,94%
ROIVANT SCIENCES LTD 1,75%
ROYALTY PHARMA PLC CLASS A 1,71%
ARGENX SE ADR 1,7%
INSMED INC 1,64%
UNITED THERAPEUTICS CORP 1,6%
INCYTE CORP 1,58%
GUARDANT HEALTH INC 1,44%
VIATRIS INC 1,32%
NEUROCRINE BIOSCIENCES INC 1,19%
ASCENDIS PHARMA 1,1%
MEDPACE HOLDINGS INC 1,05%
JAZZ PHARMACEUTICALS PLC 1,04%
BRIDGEBIO PHARMA INC 1,02%
EXELIXIS INC 0,96%
IONIS PHARMACEUTICALS INC 0,96%
AXSOME THERAPEUTICS INC 0,86%
MADRIGAL PHARMACEUTICALS INC 0,84%
SUMMIT THERAPEUTICS INC 0,83%
ARROWHEAD PHARMACEUTICALS INC 0,82%
BIOMARIN PHARMACEUTICAL INC 0,78%
CYTOKINETICS INC 0,78%
BIONTECH SE ADR 0,74%
KRYSTAL BIOTECH INC 0,73%
TEMPUS AI INC CLASS A 0,7%
BEONE MEDICINES AG 0,68%
SANOFI ADR REPRESENTING SA 0,67%
KYMERA THERAPEUTICS INC 0,66%
HALOZYME THERAPEUTICS INC 0,65%
ALKERMES 0,61%
IMMUNITYBIO INC 0,61%
NUVALENT INC CLASS A 0,61%
PROTAGONIST THERAPEUTICS INC 0,6%
PRAXIS PRECISION MEDICINES INC 0,6%
VAXCYTE INC 0,58%
CRINETICS PHARMACEUTICALS INC 0,58%
APOGEE THERAPEUTICS INC 0,56%
IMMUNOVANT INC 0,55%
ABIVAX AMERICAN DEPOSITARY SHARES 0,55%
SPYRE THERAPEUTICS INC 0,54%
RHYTHM PHARMACEUTICALS INC 0,52%
MIRUM PHARMACEUTICALS INC 0,52%
PTC THERAPEUTICS INC 0,49%
COGENT BIOSCIENCES INC 0,46%
SCHOLAR ROCK HOLDING CORP 0,45%
LIGAND PHARMACEUTICALS INC 0,43%
XENON PHARMACEUTICALS INC 0,41%
CG ONCOLOGY INC 0,41%
CRISPR THERAPEUTICS AG 0,39%
ERASCA INC 0,38%
TWIST BIOSCIENCE CORP 0,38%
AMNEAL PHARMACEUTICALS INC CLASS A 0,36%
TRAVERE THERAPEUTICS INC 0,36%
ORUKA THERAPEUTICS INC 0,34%
INDIVIOR PHARMACEUTICALS INC 0,33%
CARIS LIFE SCIENCES INC 0,33%
DEFINIUM THERAPEUTICS INC 0,32%
EDGEWISE THERAPEUTICS INC 0,31%
ACADIA PHARMACEUTICALS INC 0,3%
VERACYTE INC 0,3%
10X GENOMICS INC CLASS A 0,29%
STRUCTURE THERAPEUTICS ADR INC 0,29%
TANGO THERAPEUTICS INC 0,29%
NEWAMSTERDAM PHARMA NV 0,29%
RELAY THERAPEUTICS INC 0,28%
DENALI THERAPEUTICS INC 0,28%
DYNE THERAPEUTICS INC 0,26%
BEAM THERAPEUTICS INC 0,26%
ALUMIS INC 0,24%
IDEAYA BIOSCIENCES INC 0,24%
ULTRAGENYX PHARMACEUTICAL INC 0,23%
ARCUTIS BIOTHERAPEUTICS INC 0,23%
ADAPTIVE BIOTECHNOLOGIES CORP 0,23%
KINIKSA PHARMACEUTICALS INTERNATIO 0,21%
ENLIVEN THERAPEUTICS INC 0,21%
VERA THERAPEUTICS INC CLASS A 0,21%
DISC MEDICINE INC 0,2%
TARSUS PHARMACEUTICALS INC 0,2%
MBX BIOSCIENCES INC 0,2%
GRAIL INC 0,2%
BIOCRYST PHARMACEUTICALS INC 0,19%
SUPERNUS PHARMACEUTICALS INC 0,19%
TREVI THERAPEUTICS INC 0,18%
UNIQURE NV 0,18%
AGIOS PHARMACEUTICALS INC 0,18%
NURIX THERAPEUTICS INC 0,17%
MINERALYS THERAPEUTICS INC 0,17%
KODIAK SCIENCES INC 0,16%
VERICEL CORP 0,16%
INTELLIA THERAPEUTICS INC 0,16%
PHARVARIS N V NV 0,16%
ABCELLERA BIOLOGICS INC 0,16%
Montrer tout Cacher
Autres - %

Autres actions de ce fonds

iShares Nasdaq US Biotechnology UCITS ETF
Montrer tout

Autres ETF et fonds de ce fournisseur

ETF et fonds similaires

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} mln
    Valeur nette d'actifs
    {{ item.expense_ratio }}
    Ratio de coût total
Vous devez vous inscrire pour y accéder.